These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21253997)

  • 21. Higher Quality Evidence to Guide Our Management of Postural Orthostatic Tachycardia Syndrome: A New Era?
    Raj SR; Sheldon RS
    J Am Coll Cardiol; 2021 Feb; 77(7):872-874. PubMed ID: 33602469
    [No Abstract]   [Full Text] [Related]  

  • 22. Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.
    Olshansky B; Cannom D; Fedorowski A; Stewart J; Gibbons C; Sutton R; Shen WK; Muldowney J; Chung TH; Feigofsky S; Nayak H; Calkins H; Benditt DG
    Prog Cardiovasc Dis; 2020; 63(3):263-270. PubMed ID: 32222376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new hope in the nightmare of diabetic orthostatic hypotension: the midodrine-fludrocortisone association.
    Andreelli F; Plotton I; Thivolet C; Riou JP
    Diabetes Obes Metab; 1999 Sep; 1(5):297-8. PubMed ID: 11225642
    [No Abstract]   [Full Text] [Related]  

  • 24. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postural orthostatic tachycardia syndrome with increased erythrocytic hydrogen sulfide and response to midodrine hydrochloride.
    Yang J; Zhao J; Du S; Liu D; Fu C; Li X; Chen S; Tang C; Du J; Jin H
    J Pediatr; 2013 Oct; 163(4):1169-73.e2. PubMed ID: 23726544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow-mediated vasodilation as a predictor of therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.
    Liao Y; Yang J; Zhang F; Chen S; Liu X; Zhang Q; Ai Y; Wang Y; Tang C; Du J; Jin H
    Am J Cardiol; 2013 Sep; 112(6):816-20. PubMed ID: 23735645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A practical guide to the treatment of neurogenic orthostatic hypotension.
    Berger MJ; Kimpinski K
    Can J Neurol Sci; 2014 Mar; 41(2):156-63. PubMed ID: 24534025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyridostigmine in the treatment of orthostatic intolerance.
    Gales BJ; Gales MA
    Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome.
    Ross AJ; Ocon AJ; Medow MS; Stewart JM
    Clin Sci (Lond); 2014 Feb; 126(4):289-96. PubMed ID: 23978222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of selective alpha1 receptor agonist in the treatment of children with postural orthostatic tachycardia syndrome].
    Chen L; DU JB; Jin HF; Zhang QY; Li WZ; Wang L; Wang YL
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):688-91. PubMed ID: 19099860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocardiogenic syncope in children : current concepts in diagnosis and management.
    Massin M
    Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postural orthostatic tachycardia syndrome, neurally-mediated syncope, and joint hypermobility: a case report.
    Berganzo K; Tijero B; Zarranz JJ; Gómez-Esteban JC
    Neurologia; 2014 Sep; 29(7):447-9. PubMed ID: 23490229
    [No Abstract]   [Full Text] [Related]  

  • 33. Postural Orthostatic Tachycardia Syndrome.
    Safavi-Naeini P; Razavi M
    Tex Heart Inst J; 2020 Feb; 47(1):57-59. PubMed ID: 32148459
    [No Abstract]   [Full Text] [Related]  

  • 34. Heart rate reduction in heart failure: ivabradine or beta blockers?
    Guglin M
    Heart Fail Rev; 2013 Jul; 18(4):517-28. PubMed ID: 22972475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postural orthostatic tachycardia syndrome for the otolaryngologist.
    Bogle JM; Goodman BP; Barrs DM
    Laryngoscope; 2017 May; 127(5):1195-1198. PubMed ID: 27578452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical Trial.
    Moon J; Kim DY; Lee WJ; Lee HS; Lim JA; Kim TJ; Jun JS; Park B; Byun JI; Sunwoo JS; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
    Neurotherapeutics; 2018 Jul; 15(3):785-795. PubMed ID: 29500811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome.
    Fu Q; Vangundy TB; Shibata S; Auchus RJ; Williams GH; Levine BD
    Hypertension; 2011 Aug; 58(2):167-75. PubMed ID: 21690484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postural orthostatic tachycardia syndrome: a clinical review.
    Johnson JN; Mack KJ; Kuntz NL; Brands CK; Porter CJ; Fischer PR
    Pediatr Neurol; 2010 Feb; 42(2):77-85. PubMed ID: 20117742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker.
    Khan S; Hamid S; Rinaldi C
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):131-3. PubMed ID: 19140923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of postural tachycardia syndrome.
    Busmer L
    Nurs Stand; 2013 Jan 16-22; 27(20):44-8. PubMed ID: 23431938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.